Riders · Cancer Prevention and Research Institute of Texas · Article I: General Government

Performance Measure Targets

Rider 1 in the 2026-27 Act, page I-17

Through the session

  1. 2024-25 Act In current law rider 1
  2. Introduced (Senate) Amended rider 1
  3. Introduced (House) Amended rider 1
  4. Senate substitute Unchanged rider 1
  5. House substitute Unchanged rider 1
  6. House passed Unchanged rider 1
  7. Conference Unchanged rider 1
  8. 2026-27 Act Unchanged rider 1

Pick any two steps to compare their wording.

What changed in the text

2024-25 Act → Introduced (House): 2024 2025 became 2026 2027; 3 3 became 2 2; 750,000 750,000 became 775,000 775,000; 138 135 became 136 134.

Performance Measure Targets. The following is a listing of the key performance target levels for the Cancer Prevention and Research Institute of Texas. It is the intent of the Legislature that appropriations made by this Act be utilized in the most efficient and effective manner possible to achieve the intended mission of the Cancer Prevention and Research Institute of Texas. In order to achieve the objectives and service standards established by this Act, the Cancer Prevention and Research Institute of Texas shall make every effort to attain the following designated key performance target levels associated with each item of appropriation. 2024 2025 2026 2027 A. Goal: CANCER RESEARCH AND PREVENTION SVCS A.1.1. Strategy: AWARD CANCER RESEARCH GRANTS Output (Volume): Number of Entities Relocating to Texas for Cancer-Research Related Projects 3 3 2 2 Explanatory: Number of Published Articles on CPRIT-Funded Research Projects 1,000 1,000 Number of New Jobs Created and Maintained 3,000 3,000 A.1.2. Strategy: AWARD CANCER PREVENTION GRANTS Output (Volume): Number of Cancer Prevention and Control Services Provided by Institute Funded Grants 750,000 750,000 775,000 775,000 Explanatory: Annual Age-adjusted Cancer Mortality Rate 138 135 136 134

Removed words are struck through; added words are underlined. Sources: 2024-25 Act · Introduced (House).

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium 1 First version — Page I-18
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) 1 Amended — Page I-19
Introduced (House)House Bill 1 as introduced (LBB recommended, House) 1 Amended — Page I-18
Senate substituteCommittee Substitute for Senate Bill 1 1 Unchanged Amended Page I-17
House substituteHouse Committee Substitute for Senate Bill 1 1 Unchanged Amended Page I-17
House passedSenate Bill 1 as passed the second house 1 Unchanged Amended Page I-17
ConferenceConference Committee Report for Senate Bill 1 1 Unchanged Amended Page I-16
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium 1 Unchanged Amended Page I-17
Full text of each wording

Introduced (Senate), Introduced (House), Senate substitute, House substitute, House passed, Conference, 2026-27 Act

Source, page I-17

Performance Measure Targets. The following is a listing of the key performance target levels for the Cancer Prevention and Research Institute of Texas. It is the intent of the Legislature that appropriations made by this Act be utilized in the most efficient and effective manner possible to achieve the intended mission of the Cancer Prevention and Research Institute of Texas. In order to achieve the objectives and service standards established by this Act, the Cancer Prevention and Research Institute of Texas shall make every effort to attain the following designated key performance target levels associated with each item of appropriation.

                                                                              2026               2027

A. Goal: CANCER RESEARCH AND PREVENTION SVCS A.1.1. Strategy: AWARD CANCER RESEARCH GRANTS Output (Volume):

Number of Entities Relocating to Texas for

        Cancer-Research Related Projects                                           2                  2

Explanatory:

Number of Published Articles on CPRIT-Funded Research

        Projects                                                               1,000               1,000
       Number of New Jobs Created and Maintained                               3,000               3,000

A.1.2. Strategy: AWARD CANCER PREVENTION GRANTS Output (Volume):

Number of Cancer Prevention and Control Services

        Provided by Institute Funded Grants                                  775,000             775,000

Explanatory:

       Annual Age-adjusted Cancer Mortality Rate                                 136                134

2024-25 Act

Source, page I-18

Performance Measure Targets. The following is a listing of the key performance target levels for the Cancer Prevention and Research Institute of Texas. It is the intent of the Legislature that appropriations made by this Act be utilized in the most efficient and effective manner possible to achieve the intended mission of the Cancer Prevention and Research Institute of Texas. In order to achieve the objectives and service standards established by this Act, the Cancer Prevention and Research Institute of Texas shall make every effort to attain the following designated key performance target levels associated with each item of appropriation.

                                                                                2024               2025

A. Goal: CANCER RESEARCH AND PREVENTION SVCS A.1.1. Strategy: AWARD CANCER RESEARCH GRANTS Output (Volume):

Number of Entities Relocating to Texas for

           Cancer-Research Related Projects                                          3                  3

Explanatory:

Number of Published Articles on CPRIT-Funded Research

           Projects                                                              1,000               1,000
         Number of New Jobs Created and Maintained                               3,000               3,000

A.1.2. Strategy: AWARD CANCER PREVENTION GRANTS Output (Volume):

Number of Cancer Prevention and Control Services

        Provided by Institute Funded Grants                                 750,000             750,000

Explanatory:

       Annual Age-adjusted Cancer Mortality Rate                               138                 135